Interestingly the β-adrenoceptor antagonist propranolol is the current first-line treatment for infantile hemangioma; however, its mechanism of action is not fully understood, although it is believed to ultimately result in decreased VEGF expression and cell proliferation. The gene discussed is VEGFA; the disease is capillary hemangioma.